Close
ACHEMA MIDDLE EAST 2026

US Patent Law Suit For Actemra Solved Between Roche & Biogen

Based on a filing on October 23 in Massachusetts federal court, Roche, the Swiss pharmaceutical giant, has reached a settlement in a patent lawsuit...

Innovation Can Grow When Big Pharma & Big Tech Collaborate

Big tech along with Big Pharma have gone on to play a crucial role in elevating standards of living as well as shaping the modern age. Over...

CDMO-Biotech Ties Help Cut Business Risk In Drug Development

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high...

Improving Approach of UK Through Future Clinical Trials Bill

The Policy Exchange has come up with a report that highlights the potential benefits of The Future Clinical Trials Bill when it comes to improving...

IP Waivers, Pathogen Sharing Benefits In Draft Pandemic Deal

The draft pandemic accord, which was sent to member states of the World Health Organisation by the Intergovernmental Negotiating Body recently, includes several important...

Industry 5.0 Has Plenty To Offer To Pharma Manufacturing

In the last dozen years, Industry 4.0 has brought about a significant transformation when it comes to manufacturing technology. It has enabled machines to...

Prominent Pharma Antitrust Lawsuits Over The Last Decade

Although one must have heard of tech giants such as Microsoft, Apple, as well as Meta getting caught up in certain antitrust scandals, big...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...